| Identification | Back Directory | [Name]
OSI-754 | [CAS]
1190094-64-4 | [Synonyms]
LNK 754
OSI-754
CP 609754
CP-609754(OS1754)
CP-609754 (OSI754)
CP-609754 (OSI754, LNK 754)
6-[(R)-(4-chlorophenyl)-hydroxy-(3-methylimidazol-4-yl)methyl]-4-(3-ethynylphenyl)-1-methylquinolin-2-one
2(1H)-Quinolinone, 6-[(R)-(4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-ethynylphenyl)-1-methyl-
Malignant,farnesylation,Farnesyltransferase,Tumor,Inhibitor,LNK-754,CP-609754,H-Ras,Ftase,OSI 754,Farnesyl Transferase,LNK 754,OSI-754,inhibit,OSI754,CP 609754,LNK754,K-Ras,Advanced,CP609754 | [Molecular Formula]
C29H22ClN3O2 | [MOL File]
1190094-64-4.mol | [Molecular Weight]
479.96 |
| Chemical Properties | Back Directory | [Boiling point ]
702.4±60.0 °C(Predicted) | [density ]
1.23±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 100 mg/mL (208.35 mM; Need ultrasonic) | [form ]
Solid | [pka]
12.28±0.29(Predicted) | [color ]
Off-white to yellow |
|
| Company Name: |
SPIRO PHARMA
|
| Tel: |
|
| Website: |
www.spiropharma.com.cn |
|